Comparison of myocardial reperfusion between intracoronary versus intravenous cangrelor administration in patients undergoing primary percutaneous coronary intervention.
Iacopo MuracaMatteo PennesiAlessio MattesiniAngela MiglioriniNazario CarrabbaGiacomo VirgiliFilippo BruscoliPierluigi DemolaRiccardo ColombiGiulia PontecorboliNiccolò MarchionniCarlo Di MarioRenato ValentiPublished in: Cardiology journal (2021)
In conclusion the results of the study do not show any advantages in the administration of intracoronary bolus of cangrelor in patients affected by STEMI and treated with primary PCI.
Keyphrases
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute myocardial infarction
- st segment elevation myocardial infarction
- acute coronary syndrome
- patients undergoing
- end stage renal disease
- coronary artery disease
- newly diagnosed
- antiplatelet therapy
- coronary artery bypass grafting
- ejection fraction
- chronic kidney disease
- left ventricular
- atrial fibrillation
- prognostic factors
- peritoneal dialysis
- heart failure
- low dose
- acute ischemic stroke
- cerebral ischemia
- patient reported outcomes
- subarachnoid hemorrhage
- clinical evaluation